The Lunenfeld-Tanenbaum Research Institute
Donate Now - Mount Sinai Hospital Foundation of Toronto Lunenfeld QR code
Personal tools
Dr. Martin C. Chang
Home Researchers Dr. Martin C. Chang

Dr. Martin C. Chang

dr. martin c. chang

 

Mount Sinai Hospital
600 University Avenue
Toronto, Ontario
Canada
M5G 1X5

Tel: 416-586-4800
► Send Email

 

Dr. Martin C. Chang 
SENIOR CLINICIAN SCIENTIST

Dr. Martin Chang is Director, Breast Pathology Service and Director, Circulating Tumour Cell Programme, in Mount Sinai Hospital's Department of Pathology and Lab Medicine. He is an Associate Professor in Laboratory Medicine and Pathobiology at the University of Toronto.

He obtained his PhD (Physiology) and MD degrees from the University of Toronto and undertook further training at Brigham and Women’s Hospital (Boston) and Harvard Medical School.

As an academic anatomical pathologist, his clinical expertise is in the surgical pathology of the breast and gynecologic tract. He focuses his clinical and translational research program in these areas. His main research interest is in the clinicopathologic and molecular characterization of breast carcinoma. This includes evaluation of pathologic predictors of recurrence and treatment response; role of host factors in breast cancer progression; and molecular correlates of structural/histologic changes. Areas of research include:

  • Host factors influencing breast cancer progression: clinical/translational research
  • Role of circulating tumour cells in breast cancer prognosis and characterization
  • Clinicopathologic and molecular characterization of breast carcinoma
  • Digital pathology and informatics

 

 

 

 

At a Glance

  • Director, Breast Pathology Services and Director, Circulating Tumour Cell Programme, Mount Sinai Hospital
  • Leads a clinical and translational research program in breast and gynecological cancers

 

Major Research Activities

Dr. Chang’s main research interest is in the clinicopathologic and molecular characterization of breast carcinoma. This includes evaluation of pathologic predictors of recurrence and treatment response, role of host factors in breast cancer progression, and molecular correlates of structural/histologic changes. Other interests include ovarian cancer and digital pathology.

   

 

 

Document Actions
Ontario Health Study Faculty of Medicine, University of Toronto. mitacs honorary partner

 

 
plone
       
 
   
spinner
Facebook popup Youtube popup Twitter popup RSS popup